IT1157288B - Agenti anti-obesita' - Google Patents

Agenti anti-obesita'

Info

Publication number
IT1157288B
IT1157288B IT22209/82A IT2220982A IT1157288B IT 1157288 B IT1157288 B IT 1157288B IT 22209/82 A IT22209/82 A IT 22209/82A IT 2220982 A IT2220982 A IT 2220982A IT 1157288 B IT1157288 B IT 1157288B
Authority
IT
Italy
Prior art keywords
obesity agents
obesity
agents
Prior art date
Application number
IT22209/82A
Other languages
English (en)
Other versions
IT8222209A0 (it
Inventor
Alan Chapman White
Michael Grant Wyllie
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of IT8222209A0 publication Critical patent/IT8222209A0/it
Application granted granted Critical
Publication of IT1157288B publication Critical patent/IT1157288B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
IT22209/82A 1981-07-07 1982-07-02 Agenti anti-obesita' IT1157288B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8120961 1981-07-07

Publications (2)

Publication Number Publication Date
IT8222209A0 IT8222209A0 (it) 1982-07-02
IT1157288B true IT1157288B (it) 1987-02-11

Family

ID=10523079

Family Applications (1)

Application Number Title Priority Date Filing Date
IT22209/82A IT1157288B (it) 1981-07-07 1982-07-02 Agenti anti-obesita'

Country Status (6)

Country Link
US (1) US4451465A (it)
JP (1) JPS5815915A (it)
AU (1) AU558020B2 (it)
BE (1) BE893789A (it)
IT (1) IT1157288B (it)
ZA (1) ZA824382B (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US6344481B1 (en) 1999-03-01 2002-02-05 Pfizer Inc. Thyromimetic antiobesity agents
US7504435B2 (en) * 2001-01-31 2009-03-17 The Arizona Board Of Regents On Behalf Of The University Of Arizona Method for stimulating weight loss and/or for lowering triglycerides in patients
US7202222B2 (en) * 2003-01-06 2007-04-10 National Bioscience Corporation Methods for treatment of obesity and effective fat loss promotion
MXPA05011557A (es) 2003-04-29 2006-03-09 Orexigen Therapeutics Inc Composiciones para afectar perdida de peso.
US8916195B2 (en) * 2006-06-05 2014-12-23 Orexigen Therapeutics, Inc. Sustained release formulation of naltrexone
WO2008106213A1 (en) * 2007-02-27 2008-09-04 Titan Pharmaceuticals, Inc. Administration of 3,5-diiodothyropropionic acid for stimulating weight loss, and/or lowering triglyceride levels, and/or treatment of metabolic syndrome.
MX2010012909A (es) 2008-05-30 2011-02-25 Orexigen Therapeutics Inc Metodos para tratamiento de condiciones de grasa visceral.
KR20200035501A (ko) 2012-06-06 2020-04-03 오렉시젠 세러퓨틱스 인크. 과체중 및 비만의 치료 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2200584A1 (de) * 1971-01-11 1972-07-27 Wyeth John & Brother Ltd Heterocyclische Verbindungen,Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Zubereitungen
GB1366133A (en) * 1971-01-11 1974-09-11 Wyeth John & Brother Ltd Fused ring indole derivatives
US4307234A (en) * 1978-09-11 1981-12-22 American Home Products Corp. Pyrimido[1,6-a]indole derivatives

Also Published As

Publication number Publication date
AU8516982A (en) 1983-01-13
BE893789A (fr) 1983-01-07
IT8222209A0 (it) 1982-07-02
US4451465A (en) 1984-05-29
JPS5815915A (ja) 1983-01-29
AU558020B2 (en) 1987-01-15
ZA824382B (en) 1984-02-29

Similar Documents

Publication Publication Date Title
TR21767A (tr) N-fenilsulfonil-n'-pirimidinil-ve-triazinilureler
DK338782A (da) Substituerede n-aroyl-n'-phenyl-urinstofforbindelser
DE3472105D1 (de) 4-heterocyclyl-vinyl-4'-styryl-biphenyls
IT1157288B (it) Agenti anti-obesita'
BE893837A (fr) Vecteurs d'expression
SU1179923A3 (ru) "cпocoб пoлучehия aзoлилпehtehпpoизboдhыx"
FR2503818B1 (fr) Volant d'inertie
BR8201041A (pt) Recalcadora de via ferrea
TR21225A (tr) Aklil n-arilsulfenil-n-diariloksi-fosfinilmetilglisinat'lari
ES263696Y (es) "disposicion de fiador".
NO822578L (no) Tilhengerfeste
BR8100474A (pt) Recalcadora de via ferrea
IT8108920V0 (it) Salvacaffe'
IT8133814V0 (it) "fiorella"
IT8133811V0 (it) "essecamini-c"
IT8132801V0 (it) "vettor-drive"
IT8132827V0 (it) "for-meches"
IT8133807V0 (it) "essecamini-bis"
ES267636Y (es) "lustrador".
ES264864Y (es) "pesacartas".
SE8204225D0 (sv) "epla"
PT7061U (pt) "cigarreira - pulseira
IT8140449A0 (it) Pellicola multi-sensibilita'
IT8166702A0 (it) "pippo"
IT8166711A0 (it) "blok"